Taro Pharmaceutical Industries Ltd. (TARO)
Jun 24, 2024 - TAR was delisted (reason: acquired by Sun Pharma)
42.97
0.00 (0.00%)
Last trade price

TARO Income Statement

Millions USD. Fiscal year is Apr - Mar.
Year Ending
TTM Mar 31, 2024Mar 31, 2023Mar 31, 2022Mar 31, 2021Mar 31, 2020 2018 - 2003
Revenue
629.18629.18572.95561.35548.97644.77
Upgrade
Revenue Growth (YoY)
9.81%9.81%2.07%2.25%-14.86%-3.75%
Upgrade
Cost of Revenue
324.23324.23304.63268.23252.31245.04
Upgrade
Gross Profit
304.96304.96268.32293.12296.66399.73
Upgrade
Selling, General & Admin
218.94218.94198.37113.6891.3693.41
Upgrade
Research & Development
64.5464.5452.2454.5460.1559.78
Upgrade
Other Operating Expenses
00057.22556.03-3.02
Upgrade
Operating Expenses
283.47283.47250.61225.44707.54150.17
Upgrade
Operating Income
21.4921.4917.7167.69-410.88249.55
Upgrade
Interest Expense / Income
000-10.17-19.81-48.48
Upgrade
Other Expense / Income
-61.18-61.18-20.5--14.090.31
Upgrade
Pretax Income
82.6782.6738.2177.86-376.99297.73
Upgrade
Income Tax
28.828.812.7719.599.6753.49
Upgrade
Net Income
53.8753.8725.4558.27-386.65244.24
Upgrade
Net Income Growth
111.70%111.70%-56.33%---13.32%
Upgrade
Shares Outstanding (Basic)
383838383838
Upgrade
Shares Outstanding (Diluted)
383838383838
Upgrade
Shares Change
---0.15%-1.49%-0.65%-1.36%
Upgrade
EPS (Basic)
1.431.430.681.55-10.126.35
Upgrade
EPS (Diluted)
1.431.430.681.55-10.126.35
Upgrade
EPS Growth
110.29%110.29%-56.13%---12.17%
Upgrade
Free Cash Flow
70.5870.5814.2-170.528.78244.97
Upgrade
Free Cash Flow Per Share
1.881.880.38-4.530.756.37
Upgrade
Gross Margin
48.47%48.47%46.83%52.22%54.04%62.00%
Upgrade
Operating Margin
3.41%3.41%3.09%12.06%-74.85%38.70%
Upgrade
Profit Margin
8.56%8.56%4.44%10.38%-70.43%37.88%
Upgrade
Free Cash Flow Margin
11.22%11.22%2.48%-30.37%5.24%37.99%
Upgrade
Effective Tax Rate
34.84%34.84%33.41%25.16%-17.96%
Upgrade
EBITDA
113.76113.7670.3493.6-373.12270.63
Upgrade
EBITDA Margin
18.08%18.08%12.28%16.67%-67.97%41.97%
Upgrade
Depreciation & Amortization
31.0931.0932.1325.9223.6821.38
Upgrade
EBIT
82.6782.6738.2167.69-396.8249.24
Upgrade
EBIT Margin
13.14%13.14%6.67%12.06%-72.28%38.66%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).